Introduction
Expert working teams formulated the Rome diagnostic criteria, positive symptom-based criteria for the irritable bowel syndrome (IBS) and other functional bowel disorders (FBDs) in an ongoing process [1] . The latest iteration, the Rome III criteria, was recently published [2] . The Rome III criteria require a lower frequency of symptoms than Rome II (at least 3 days/month, that is, at least 10% of the time over the past 3 months for Rome III, compared with at least 25% of the time over the past 12 months for Rome II) [2, 3] . The new criteria also distinguish more clearly between IBS subtypes that are now defined as IBS with diarrhea, IBS with constipation, or IBS mixed (symptoms of constipation and diarrhea in the same patient). The Rome II criteria missed some patients in the last subcategory.
Accurately determining the epidemiology of IBS and other FBDs is important because it serves as the basis for assessing the burden of disease in socio-cultural, healthcare and economic terms. It can also be of significance in the allocation of research funding and in the efforts invested by pharmaceutical companies into the development of new treatments.
All iterations of the diagnostic criteria, including pre-Rome criteria such as the Manning criteria [4] have led to different estimates of the prevalence rates of these disorders. In general, the estimated rates have declined in most studies, so that rates of IBS and other FBDs have been lower using Rome II than Rome I, which was lower in many cases than when the Manning criteria were used [5] .
Depending on the diagnostic criteria, the country surveyed and the methodology used, most estimates of the prevalence of IBS have usually been in the range of 8-20% [6, 7] . Recent studies from around the world using the Rome II criteria, however, have reported lower prevalence rates, in some cases below 5% or even lower than 3% [8] [9] [10] . Thus, it is difficult to define a range of values that can be confidently referred to as an accurate estimation of the true prevalence rate of these disorders.
Using the Rome II criteria to estimate the prevalence of IBS and other FBDs in an epidemiological survey of a representative sample of adult Israeli Jews, we recently reported a prevalence rate of 2.9% for IBS (4.1% after adjusting for alternators who were missed with the formal Rome II criteria) [10] . Not only are these rates unexpectedly low but also they raise the question of whether the Rome II diagnostic criteria are overly strict resulting in an underestimation of the true prevalence rates.
The official Rome II integrative questionnaire used for our previous study can also serve to approximate prevalence rates in accordance with the Rome III criteria, as explained in the methods (below). With the publication of the Rome III criteria, we conducted additional retrospective analyses on our study database comparing Rome II and Rome III criteria for IBS and all FBDs.
Material and methods

Instrument
The questionnaire items relating to diagnoses of IBS and other FBDs were adopted, per se, from the integrative questionnaire recommended by the official report of the Rome Committee [11] for epidemiological studies. The questionnaire also included items on socio-demographic background, reported health services utilization (doctor visits, hospitalizations, gastrointestinal and/or obstetricalgynecological surgery) and general medical history. The questionnaire was translated to Hebrew, back-translated to English and the translation was validated using a method developed and published by the principal investigator [12, 13] .
The frequency response options to symptom questions in the integrative Rome II questionnaire are: (i) 'not at all or rarely'; (ii) 'occasionally' (further defined as more than 10% and less than 25% of the time); (iii) 'often' (up to 50% of the time); (iv) 'very often' (more than 50% of the time); and (v) 'almost always' [14] . To meet the Rome II criteria a response of 'often', 'very often', or 'almost always', that is, at least 25% of the time, is required. A response of 'occasionally', that is, at least 10% of the time, however, fulfils the Rome III criteria. This enabled us to reanalyze our data comparing the two criteria.
Responders to the Rome II questionnaire who gave a response of 'occasionally' for both diarrhea and constipation-related items (so-called 'alternators') were not diagnosed as suffering from IBS by the Rome II criteria, because they did not give a response of 'often' to either item. Thus, Rome II may have underdiagnosed IBS because if, for example, an individual experienced diarrhea 12.5% of the time and constipation 12.5% of the time, although their bowels were disordered 25% of the time they would not have been diagnosed as IBS in the Rome II system. This inconsistency is no longer a consideration with the Rome III criteria.
Diagnostic groups
The Rome II and Rome III diagnostic criteria for IBS are presented in Table 1 To address the issue of missed cases of IBS-M with the Rome II criteria, we defined as IBS-M (alternators) any participant who gave a response equivalent to 10% of the time or more for both diarrhea and constipation items. This yielded an 'adjusted Rome II' prevalence that included alternators who were previously missed. The results are presented, therefore, for three groups: Rome II, 'adjusted Rome II', and Rome III.
Study populations and data collection
The methods of the study have been reported in detail previously [10] . In brief, the Israel Ministry of the Interior prepared a large database with a representative sample of 10 000 Israeli adults. The database was prepared with the specification that it be representative of the adult population of Israel in terms of age and sex. We conducted parallel surveys of Israeli Arabs and Israeli Bedouins [15] . These studies, however, could not be conducted using the exact same methodology, or combined, because of important differences among the Recurrent abdominal pain or discomfort at least 3 days/month in last 3 months associated with two or more a : Relieved with defecation; and/or Improved with defecation; Onset associated with a change in frequency of stool; and/or Onset associated with a change in frequency of stool; Onset associated with a change in form (appearance) of stool.
Onset associated with a change in form (appearance) of stool.
IBS, irritable bowel syndrome.
a Criteria fulfilled for last 3 months with symptom onset at least 6 months before diagnosis. population groups, so the results are being reported separately.
Telephone interviews
Three trained interviewers, who introduced the survey with text approved by the institute's Helsinki Committee, conducted the telephone interviews.
Response rates
We attempted to reach 1839 individuals, 1221 successfully. The other 618 could not be reached for technical reasons, such as disconnected telephones, moving to another residence, not at home despite several tries to reach them, etc. When 1000 interviews were conducted, the survey was terminated. The overall response rate was 54% (1000/1839). The response rate among the 1221 individuals who were successfully contacted was 81.9%.
Statistical analyses
Statistical analyses were conducted using the SPSS software (SPSS Inc., Chicago, Illinois, USA). The w 2 statistic or t-tests and analysis of variance were used for group comparisons of proportions or means. A multivariate analysis (logistic regression) was conducted to assess the relative contribution of variables that were significantly associated with IBS or other FBDs on univariate analysis, and to detect interactions between variables. Statistical significance was determined at P < 0.05 throughout. Means are reported as ± SD (standard deviation).
Results
The final study population of individuals with valid questionnaires was 981 (of 1000 completed questionnaires). Fifty five percent of the respondents were women. The percentage of women in the entire Israeli population above the age of 20 years at the time of the study was 51.1%. The mean age was 45.0 ± 14.4 (men 45.9 ± 14.5 vs. women 44.2 ± 14.2; NS) and the mean level of education was 13.1 ± 3.5 years (men 13.0 ± 3.5 vs. women 13.2 ± 3.5; NS).
Prevalence of irritable bowel syndrome or any functional bowel disorder Irritable bowel syndrome
Prevalence rates for IBS and FBDs using the three diagnostic categories are presented in Table 2 . In all, 2.9% met the Rome II criteria for IBS (women 3.7%, men 1.8%, P = 0.08, 0.9% IBS-D and 1.6% for IBS-C), 4.1% met the 'adjusted' Rome II criteria (women 5.2%, men 2.7%, P = 0.05, 0.9% for IBS-D and 1.6% for IBS-C) and 11.4% met the Rome III criteria (women 13.0%, men 9.5%, P = 0.09, 1.8% for IBS-D, and 4.2% for IBS-C). for Rome II and Rome III, respectively; P < 0.01 for both).
Consultation patterns
Consultation patterns for IBS or any FBD, by Rome II and Rome III, are presented in Fig. 1 . A consistent gradient of consultation rates exists that is inversely related to the prevalence of the disorder. The highest consultation rates are seen for IBS by Rome II, and the lowest rates for any FBD by Rome III.
Multivariate logistic regression analyses (Tables 5 and 6) Two variables were significantly associated with the diagnosis of IBS by both Rome II and Rome III criteria. These were doctor visits for GI symptoms over the past 12 months (P = 0.04 and P < 0.001 for Rome II and III, respectively) and previous intestinal surgery (primarily appendectomy), (P = 0.005 and 0.001, respectively). Stress as an influence on GI symptoms was also significantly associated with IBS using Rome II criteria (P = 0.04).
Two variables were also significantly associated with the diagnosis of any FBD using either Rome II or Rome III criteria. These were doctor visits for GI symptoms over the past 12 months (P < 0.001 and P = 0.002, respectively) and stress as an influence on GI symptoms (P < 0.001 for each). A negative global feeling of wellbeing was also significantly associated with any FBD using Rome II criteria (P < 0.001).
Discussion
The prevalence of IBS varies depending on the diagnostic criteria, the method of selection of the study population and the survey method. Although prevalence rates are usually reported in review papers as ranging from 8 to 20% [6, 7] , published papers have reported rates ranging from as low as 3% or below [8] [9] [10] to as high as 30% [16] . There appears to be a trend for reduced rates as the diagnostic criteria have evolved from the earlier Manning criteria through the Rome I criteria to the currently used Rome II criteria, although results of various studies are not always consistent [5, 9, [17] [18] [19] [20] [21] [22] , as Rome II has yielded higher rates than Rome I in some studies.
Other studies from non-Western countries using Rome II have also reported low prevalence rates for IBS. In Singapore [8] , the overall prevalence of IBS was 2.3%. A similar rate of IBS was found in a study conducted in Hong Kong among ethnic Chinese individuals [23] with a prevalence of 4.1%. In Iran the reported rate of IBS was 5.8% [24] , and in urban Turkey 6.3% [25] . An especially low rate of 0.82% was reported from China [20] .
In a recent publication, however, Gwee [26] states that although IBS is traditionally considered to be less prevalent in Asia than in the West, this may stem from underdiagnosis owing to a different presentation of the disorder. Thus, he proposes that actual prevalence rates in Asia have become similar to those in Western countries.
A recent study from France [9] assessed prevalence rates by the Manning, Rome I and Rome II criteria. The overall prevalence rate for IBS was 2.6% for at least one of the criteria and only 1.1% based on the Rome II criteria, indicating that low prevalence rates are also seen in Western countries.
The overall prevalence of IBS in our study population using the Rome II criteria is 2.9%, with a female/male ratio of 3.7-1.8%, and 11.4% with female/male ratio of 13.0-9.5% male using Rome III. In a previous unpublished study using the Rome I criteria, we found an overall rate of 5.5% for IBS among Jews (7.6% women and 2.1% men). These rates were unexpectedly low and did not seem to be in line with clinical experience or 'common knowledge'. The very high consultation rates found using Rome II criteria also shed some doubt as to whether these criteria were identifying patients with all degrees of severity or selecting out a more severely ill subgroup of IBS patients.
Our impression from the results of the present study is that the Rome III criteria may more closely reflect the burden of disease and epidemiological features of IBS than Rome II. The following discussion presents some of the data that appear to back this impression.
Sex and consultation rates
The preponderance of women and the finding that the majority of individuals who meet the criteria for IBS do not consult physicians for their symptoms are almost universal, although there is some evidence for a different female/male ratio in Asia [26] .
The percentage of consulters (57%) for Rome II is higher than most previous reports, possibly reflecting the fact CI, confidence interval; GI, gastrointestinal; IBS, irritable bowel syndrome; RR, rate ratio; SEM, standard error of means. Few studies in the literature have reported overall FBD rates. The major study that assessed FBDs with Rome II criteria found an overall rate of 41.6% with IBS accounting for 12.1% [27] . Functional constipation and functional abdominal bloating were the major diagnoses of FBD other than IBS. The US householder survey using Rome I criteria reported an overall FBD rate of 44.1% with functional abdominal bloating accounting for 30.7% [28] . Thus, the overall rates in these studies were considerably higher than those that we found for Rome II, but were reasonably similar to those found by us for Rome III. In addition, the finding that functional abdominal bloating and functional constipation represent the bulk of other FBDs is consistent in all three studies.
Age and income
IBS is considered a disorder of the relatively young, although many clinicians treat older patients with IBS [28, 29] . The finding that participants with IBS by Rome III are significantly younger than those without IBS, whereas no such difference was found for Rome II, also supports the impression that the Rome III identifies a more characteristic IBS population than does Rome II.
The mean income was significantly below the national average for a greater percentage of IBS sufferers than for those without IBS, by both Rome II and Rome III. This finding is consistent with the results of a study from the United States in which functional disorders were more common among lower income groups [28] .
Finally, the results of the multivariate analyses indicate a strong association between IBS or any FBD and doctor visits for GI symptoms in all diagnostic categories. Stress was also found to be strongly associated with IBS and other FBDs, except for IBS by Rome III. Interestingly, previous intestinal surgery, primarily appendectomy, was significantly associated with IBS for both Rome II and Rome III, but not with any FBD, by either criteria. This may indicate that the putative 'insult' of intestinal surgery is related to chronic pain more than to disturbances in motility.
The primary limitation of this study is that the Rome III prevalence rates are not based on an official Rome III questionnaire, but on reanalysis of the data from the Rome II questionnaire, adjusted to approximate the results anticipated using Rome III diagnostic criteria. Subtle changes in wording between the Rome II and pending Rome III integrative questionnaires could yield different prevalence rates than obtained with the retrospective method used in the present study. Despite this reservation, we believe that the adaptation of the Rome II questionnaire that we used provides a close approximation of the actual Rome III prevalence rates. This belief is based on the close similarity of the questions and response options to the Rome III criteria. In addition, the results are more consistent with worldwide epidemiological trends than our previous Rome II results. Furthermore, the analyses of consultancy rates and associations between IBS and sociodemographic and health-related variables appear to yield more logical and consistent results than those found with the Rome II criteria. The latter showed an unexpectedly low prevalence rate for IBS together with higher than expected consultation rates. Taken together, these findings would seem to indicate that the Rome II criteria selected out a subset of patients with more severe IBS. The results for Rome III, viewed from this perspective, appear to be less rigid and to more accurately reflect the epidemiology of the disorder.
In conclusion, although it is clear that IBS and other FBDs are common and add substantially to the health care burden, epidemiological data from around the world have been inconsistent. Hopefully, the new Rome III criteria will help to clarify these inconsistencies. The present retrospective comparison of prevalence rates for IBS and other FBDs using the Rome II and Rome III diagnostic criteria in a large representative sample of the adult Jewish population of Israel showed that IBS rates are substantially higher using the Rome III criteria. For reasons discussed in this paper, we believe that the Rome III findings may more accurately reflect the burden of disease and epidemiological features of the disorder. Prospective studies, using the soon to be published official Rome III questionnaire, should further clarify this important issue.
